Skip to content
Find Clinical Trials
Find Clinical Trials
Home » Find Clinical Trials » Long-term efficacy and safety of agomelatine in non-depressed out-patients with Generalized Anxiety Disorder.A 26-week randomised double-blind placebo-controlled parallel group study following an open-label period of 16 weeks with agomelatine (25mg/day with the possibility for blinded dose-adjustment to 50mg/day).

Long-term efficacy and safety of agomelatine in non-depressed out-patients with Generalized Anxiety Disorder.A 26-week randomised double-blind placebo-controlled parallel group study following an open-label period of 16 weeks with agomelatine (25mg/day with the possibility for blinded dose-adjustment to 50mg/day).

Share Print
Servier Protocol Code: CL3-20098-050 Sponsor: Institut de Recherches Internationales Servier (I.R.I.S) EudraCT Number: 2006-005674-47

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00
Results
English (USA)
Interventions / Treatments
  • Generalised Anxiety Disorder
  • AGOMELATINE
  • S020098
Other study id numbers
  • CL3-20098-050